» Articles » PMID: 24429401

The Three-year Incidence of Fracture in Chronic Kidney Disease

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 2014 Jan 17
PMID 24429401
Citations 118
Authors
Affiliations
Soon will be listed here.
Abstract

Knowing a person's fracture risk according to their kidney function, gender, and age may influence clinical management and decision-making. Using healthcare databases from Ontario, Canada, we conducted a cohort study of 679,114 adults of 40 years and over (mean age 62 years) stratified at cohort entry by estimated glomerular filtration rate ((eGFR) 60 and over, 45-59, 30-44, 15-29, and under 15 ml/min per 1.73 m(2)), gender, and age (40-65 and over 65 years). The primary outcome was the 3-year cumulative incidence of fracture (proportion of adults who fractured (hip, forearm, pelvis, or proximal humerus) at least once within 3-years of follow-up). Additional analyses examined the fracture incidence per 1000 person-years, hip fracture alone, stratification by prior fracture, stratification by eGFR and proteinuria, and 3-year cumulative incidence of falls with hospitalization. The 3-year cumulative incidence of fracture significantly increased in a graded manner in adults with a lower eGFR for both genders and both age groups. The 3-year cumulative incidence of fracture in women over 65 years of age across the 5 eGFR groups were 4.3%, 5.8%, 6.5%, 7.8%, and 9.6%, respectively. Corresponding estimates for men over 65 years were 1.6%, 2.0%, 2.7%, 3.8%, and 5.0%, respectively. Similar graded relationships were found for falls with hospitalization and additional analyses. Thus, many adults with chronic kidney disease will fall and fracture. Results can be used for prognostication and guidance of sample size requirements for fracture prevention trials.

Citing Articles

The effects of type 1 and type 2 diabetes mellitus on bone health in chronic kidney disease.

Aleksova J, Ebeling P, Elder G Nat Rev Endocrinol. 2025; .

PMID: 39820573 DOI: 10.1038/s41574-024-01083-8.


Association between psoas muscle mass index and bone mineral density in patients undergoing hemodialysis.

Ito K, Ookawara S, Sanayama H, Kakuda H, Kanai C, Iguchi K Sci Rep. 2025; 15(1):544.

PMID: 39748056 PMC: 11696570. DOI: 10.1038/s41598-024-84873-4.


Surgical vs. conservative treatment for hip osteoporotic fracture in maintenance hemodialysis patients: a retrospective analysis.

Zhang M, Song W, Wang J, Lv R, Zhao F, Yang D Front Surg. 2024; 11:1471101.

PMID: 39713805 PMC: 11659257. DOI: 10.3389/fsurg.2024.1471101.


Real-world fracture risk, osteoporosis treatment status, and mortality of Japanese non-dialysis patients with chronic kidney disease stages G3-5.

Imanishi Y, Taniuchi S, Kodama S, Yoshida H, Ito T, Kawai R Clin Exp Nephrol. 2024; 29(2):236-247.

PMID: 39402308 PMC: 11828842. DOI: 10.1007/s10157-024-02562-y.


Association between renal function and fracture incidence during treatment with teriparatide or alendronate: an exploratory subgroup analysis of the Japanese Osteoporosis Intervention Trial-05.

Takeuchi Y, Tanaka S, Kuroda T, Hagino H, Mori S, Soen S Osteoporos Int. 2024; 35(12):2175-2182.

PMID: 39343826 PMC: 11579086. DOI: 10.1007/s00198-024-07260-9.